BR Trials - Pesquisa Clínica

São Paulo, São Paulo 03325-050

3 studies enrolling now · 5 studies all time

What they study most

Alzheimer Disease, COVID-19 Pneumonia, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Psychosis Associated With Alzheimer's Disease

Studies at this site

• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) — Recruiting now
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia — Completed